1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6C0895E7AF8A1A0CB65257D41001E9E5D
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/white-paper-health-outcomes-liaison-excellence-how-hol-function-drives-value-across-healthcare-industry?opendocument
18
19opendocument
2018.206.194.83
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25RAS




Products & Services

White Paper: Health Outcomes Liaison Excellence: How the HOL Function Drives Value Across the Healthcare Industry

Whitepaper Image

ID: BEB-54


Pages/Slides: 6


Published: 2014


Delivery Format: PDF


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Download White Paper

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
Please click on "Buy Now" to obtain the white paper on “Health Outcomes Liaison Excellence: How the HOL Function Drives Value Across the Healthcare Industry.”

Health Outcomes Liaisons (HOLs) serve as a scientific bridge between healthcare firms and important customer groups such as physicians, payers, patients and advocates. In a dynamic business environment, biopharmaceutical and medical device companies need to know how to fully leverage the relatively new, field-based HOL function.

This white paper examines the best practices in HOL management and identifies future trends expected to impact the HOL function. It is designed to help pharma and biotech leaders identify how leading companies deliver exceptional HOL services and maximize utility of health outcomes liaison staff. The study presents insights and metrics around the number of HOL interactions with payers, average length of HOL face-to-face visits and the number of products supported by HOLs.

If you would like to purchase the full study this summary is based on
click here.

Industries Profiled:
Consulting; Biotech; Medical Device; Pharmaceutical; Diagnostic; Clinical Research; Communications


Companies Profiled:
Pharma; Biotech; Medical Device Companies